These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 550129)

  • 1. Methadone exposure in utero: developmental status at one and two years of age.
    Kaltenbach K; Graziani LJ; Finnegan LP
    Pharmacol Biochem Behav; 1979; 11 Suppl():15-7. PubMed ID: 550129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental outcome of children born to methadone maintained women: a review of longitudinal studies.
    Kaltenbach K; Finnegan LP
    Neurobehav Toxicol Teratol; 1984; 6(4):271-5. PubMed ID: 6392916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal abstinence syndrome, pharmacotherapy and developmental outcome.
    Kaltenbach K; Finnegan LP
    Neurobehav Toxicol Teratol; 1986; 8(4):353-5. PubMed ID: 3762845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polydrug-using adolescent mothers and their infants receiving early intervention.
    Field TM; Scafidi F; Pickens J; Prodromidis M; Pelaez-Nogueras M; Torquati J; Wilcox H; Malphurs J; Schanberg S; Kuhn C
    Adolescence; 1998; 33(129):117-43. PubMed ID: 9583666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of methadone on thyroid function in mother, fetus, and newborn.
    Jhaveri RC; Glass L; Evans HE; Dube SK; Rosenfeld W; Khan F; Salazar JD; Chandavasu O
    Pediatrics; 1980 Mar; 65(3):557-61. PubMed ID: 7189054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18 months of age.
    Vohr BR; Poindexter BB; Dusick AM; McKinley LT; Wright LL; Langer JC; Poole WK;
    Pediatrics; 2006 Jul; 118(1):e115-23. PubMed ID: 16818526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-for-gestational-age (SGA) infants born at term: growth and development during the first year of life.
    Markestad T; Vik T; Ahlsten G; Gebre-Medhin M; Skjaerven R; Jacobsen G; Hoffman HJ; Bakketeig LS
    Acta Obstet Gynecol Scand Suppl; 1997; 165():93-101. PubMed ID: 9219465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal nonnarcotic substance abuse during pregnancy: effects on infant development.
    Chasnoff IJ; Schnoll SH; Burns WJ; Burns K
    Neurobehav Toxicol Teratol; 1984; 6(4):277-80. PubMed ID: 6514088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Information processing and developmental assessments in 3-month-old infants exposed prenatally to cocaine.
    Mayes LC; Bornstein MH; Chawarska K; Granger RH
    Pediatrics; 1995 Apr; 95(4):539-45. PubMed ID: 7700755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early intervention promotes intellectual development of premature infants: a preliminary report. Early Intervention of Premature Infants Cooperative Research Group.
    Bao X; Sun S; Wei S
    Chin Med J (Engl); 1999 Jun; 112(6):520-3. PubMed ID: 11605609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal drug exposure: effects on neonatal and infant growth and development.
    Chasnoff IJ; Burns KA; Burns WJ; Schnoll SH
    Neurobehav Toxicol Teratol; 1986; 8(4):357-62. PubMed ID: 3762846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal methadone exposure: effects on behavior in early infancy.
    Johnson HL; Rosen TS
    Pediatr Pharmacol (New York); 1982; 2(2):113-20. PubMed ID: 12760403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of 1-day and 4-month motor functioning in infants of women on methadone.
    Marcus J; Hans SL; Jeremy RJ
    Neurobehav Toxicol Teratol; 1982; 4(4):473-6. PubMed ID: 7121699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug withdrawal in newborns - clinical data of 49 infants with intrauterine drug exposure: what should be done?].
    Bläser A; Pulzer F; Knüpfer M; Robel-Tillig E; Vogtmann C; Nickel P; Kiess W
    Klin Padiatr; 2008; 220(5):308-15. PubMed ID: 18260044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal addiction: a two-year study. Part I. Clinical and developmental characteristics of infants of mothers on methadone maintenance.
    Ramer CM; Lodge A
    Addict Dis; 1975; 2(1-2):227-34. PubMed ID: 1163366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal malnutrition: an experimental study of its consequences on infant development in two caregiving environments.
    Zeskind PS; Ramey CT
    Child Dev; 1978 Dec; 49(4):1155-62. PubMed ID: 738150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polydrug- and methadone-addicted newborns: a continuum of impairment?
    Chasnoff IJ; Hatcher R; Burns WJ
    Pediatrics; 1982 Aug; 70(2):210-3. PubMed ID: 7099786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal narcotic exposure: perinatal and developmental effects.
    Kaltenbach KA; Finnegan LP
    Neurotoxicology; 1989; 10(3):597-604. PubMed ID: 2696902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acoustic cry characteristics of infants exposed to methadone during pregnancy.
    Quick ZL; Robb MP; Woodward LJ
    Acta Paediatr; 2009 Jan; 98(1):74-9. PubMed ID: 18826491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of a methadone treatment program upon pregnant heroin addicts and their newborn infants.
    Harper RG; Solish GI; Purow HM; Sang E; Panepinto WC
    Pediatrics; 1974 Sep; 54(3):300-5. PubMed ID: 4416175
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.